Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$153.8M
+21.1% from 2023
Prescriptions
1.8M
$87.15 per claim
Patients
708K
194,635 prescribers
Total spending, 2024
$153.8M
$217.04 per patient
Medicare prescription drug plans paid $153.8M for Nano 2nd Gen Pen Needle in 2024, for 1,764,310 prescriptions and refills to 708,427 patients (up 21.1% from 2023). The average cost per claim was $87.15.
California had the highest Medicare cost for Nano 2nd Gen Pen Needle in 2024: $16.2M for 243,611 claims, followed by Florida ($11.5M).
Vishal Bhatia, endocrinology in Evansville, IN, had the highest Medicare cost for Nano 2nd Gen Pen Needle in 2024: 669 claims costing $111K.
Nano 2nd Gen Pen Needle is made by Embecta Corp. (EMBC), listed in the Medicare spending data as Bd Diabetes/Emb.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Vishal Bhatia Evansville, IN | Endocrinology | 669 | 298 | $111K |
| Ronald B Villanueva Lakewood, NJ | Endocrinology | 605 | 257 | $74K |
| Oscar T Ortiz |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 162,924 | 1,279,136 | 519,682 | $108.8M |
| 2023 | 174,746 | 1,441,032 | 593,534 | $127.0M |
| 2024 | 194,635 | 1,764,310 | 708,427 | $153.8M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 586 |
| 264 |
| $72K |
| Michael J Mellman Boynton Beach, FL | Endocrinology | 631 | 278 | $69K |
| K. G Thampy Saint Louis, MO | Endocrinology | 369 | 167 | $67K |
| Eugenio Angueira-Serrano Miami, FL | Endocrinology | 988 | 362 | $64K |
| Arelis M Madera Port Charlotte, FL | Endocrinology | 415 | 225 | $61K |
| Ahmet B Ergin Port St Lucie, FL | Endocrinology | 434 | 225 | $59K |
| Mohamed F Zeitoun Hobart, IN | Endocrinology | 477 | 185 | $58K |
| Bashar G Saad San Dimas, CA | Endocrinology | 520 | 232 | $56K |
| Nadia Khoury Southgate, MI | Endocrinology | 398 | 196 | $55K |
| Arti Patel King of Prussia, PA | Endocrinology | 398 | 163 | $54K |
| Joselito C Cabaccan San Jose, CA | Endocrinology | 372 | 151 | $54K |
| Monica G Robles Anniston, AL | Endocrinology | 323 | 145 | $51K |
| Francis C Arce Oswego, NY | Internal Medicine | 408 | 128 | $50K |
| Gerald M Goltz Sewickley, PA | Endocrinology | 389 | 140 | $49K |
| Abdul Al-Kassab Rochester Hills, MI | Endocrinology | 328 | 147 | $48K |
| Helen L Slone Vineland, NJ | Endocrinology | 407 | 164 | $47K |
| Sumbul A Ali Spring Hill, FL | Endocrinology | 348 | 145 | $47K |
| Christine Kha Downey, CA | Endocrinology | 366 | 175 | $47K |
| Juan D Palacios Merchan Edinburg, TX | Endocrinology | 402 | 160 | $46K |
| Stephan Kowalyk Greensburg, PA | Endocrinology | 640 | 220 | $46K |
| Somera Ali Limerick, PA | Endocrinology | 454 | 170 | $46K |
| Marina Basina Stanford, CA | Endocrinology | 307 | 130 | $45K |
| Amer Kassar Dekalb, IL | Internal Medicine | 328 | 166 | $45K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Bd Diabetes/Emb EMBC | 1,764,963 | $153.8M |